CVS Caremark also supports organizations engaging in health care related research. In what will be one of the industry’s most comprehensive reviews of the issue of prescription adherence and compliance, CVS Caremark awarded a grant to Harvard University and Brigham and Women’s Hospital for a collaborative project with CVS Caremark to better understand why people who receive prescriptions for the treatment of acute and chronic illnesses either never purchase their medications or abandon prescription therapy before it is complete. The CVS Caremark and Harvard collaboration will also study how therapeutic complexity—where individuals may be prescribed multiple medications for the treatment of chronic illnesses—makes it more likely a person will stop taking one or more of their medications. This major study will also review the effect that e-prescribing and the provision of financial incentives through benefit plan design may have on whether a patient follows their prescribed therapy.
2008 CVS Caremark Corporate Social Responsibility Report
Download the 2008 CSR Report